Government plans database of drugs to prevent use of similar brand names

DTAB, country’s highest drug advisory body, will discuss a mechanism to this effect at its meeting on Thursday because the problem is extensive and spread across the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SiJv1r
via IFTTT